Cargando…

A Randomized Controlled Trial of Allopurinol in Patients With Peripheral Arterial Disease

BACKGROUND: Patients with peripheral arterial disease (PAD) are limited by intermittent claudication in the distance they can walk. Allopurinol has been shown in coronary arterial disease to prolong exercise before angina occurs, likely by prevention of oxygen wastage in tissues and reduction of har...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robertson, Alan J., Struthers, Allan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pulsus Group 2016
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742517/ https://www.ncbi.nlm.nih.gov/pubmed/26277090 http://dx.doi.org/10.1016/j.cjca.2015.05.010

Ejemplares similares

A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis Patients
por: Rutherford, Elaine, et al.
Publicado: (2020)

Allopurinol in Patients with Pulmonary Hypertension Associated with Chronic Lung Disease
por: Liu-Shiu-Cheong, Patrick S K, et al.
Publicado: (2020)

Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress
por: George, Jacob, et al.
Publicado: (2009)

Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial
por: Noman, Awsan, et al.
Publicado: (2010)

Effects of Allopurinol on Arterial Stiffness: A Meta-Analysis of Randomized Controlled Trials
por: Deng, Gang, et al.
Publicado: (2016)

Impact of allopurinol use on urate concentration and cardiovascular outcome
por: Wei, Li, et al.
Publicado: (2011)

An Open‐Label Dose‐Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients
por: Rutherford, Elaine, et al.
Publicado: (2017)

A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial
por: Mohan, Mohapradeep, et al.
Publicado: (2019)

Effect of allopurinol on phosphocreatine recovery and muscle function in older people with impaired physical function: a randomised controlled trial
por: Witham, Miles D, et al.
Publicado: (2020)

Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertension
por: Gingles, Christopher R., et al.
Publicado: (2019)

A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial
por: Brown, Alexander J M, et al.
Publicado: (2020)

Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study
por: Mackenzie, Isla S, et al.
Publicado: (2016)

Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout
por: Kang, Eun Ha, et al.
Publicado: (2021)

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol
por: Perez-Ruiz, Fernando, et al.
Publicado: (2016)

Comparison between febuxostat and allopurinol uric acid-lowering therapy in patients with chronic heart failure and hyperuricemia: a multicenter randomized controlled trial
por: Suzuki, Satoshi, et al.
Publicado: (2021)

Allopurinol and endothelial function: A systematic review with meta‐analysis of randomized controlled trials
por: Alem, Manal M.
Publicado: (2018)

Allopurinol for Secondary Prevention in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ye, Yuyang, et al.
Publicado: (2023)

Hepatic Safety of Febuxostat and Allopurinol for Gout Patients: A Systematic Review of Randomized Controlled Trial
por: Dewi, Christiyanti, et al.
Publicado: (2023)

Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study
por: Fayed, Ahmed, et al.
Publicado: (2023)

N-acetyl cysteine versus allopurinol in the prevention of contrast nephropathy in patients with chronic kidney disease: A randomized controlled trial
por: Sadineni, R., et al.
Publicado: (2017)

Allopurinol Effects on Residual Renal Function in End-Stage Renal Disease Patients Undergoing Peritoneal Dialysis: Randomized Controlled Trial
por: Moeinzadeh, Firouzeh, et al.
Publicado: (2019)

Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia
por: Zhang, Melissa, et al.
Publicado: (2019)

Meta-analysis on allopurinol preventive intervention on contrast-induced acute kidney injury with random controlled trials: PRISMA
por: Ma, Guang, et al.
Publicado: (2019)

Allopurinol, Benzbromarone, or a Combination in Treating Patients with Gout: Analysis of a Series of Outpatients
por: Azevedo, Valderilio Feijó, et al.
Publicado: (2014)

Effects of allopurinol on renal function in patients with diabetes: a systematic review and meta-analysis
por: Luo, Qian, et al.
Publicado: (2022)

Allopurinol and Nitric Oxide Activity in the Cerebral Circulation of Those With Diabetes: A randomized trial
por: Dawson, Jesse, et al.
Publicado: (2009)

Twenty‐Year Predictors of Peripheral Arterial Disease Compared With Coronary Heart Disease in the Scottish Heart Health Extended Cohort (SHHEC)
por: Tunstall‐Pedoe, Hugh, et al.
Publicado: (2017)

Effects of Isometric Handgrip Training in Patients With Peripheral Artery Disease: A Randomized Controlled Trial
por: A. Correia, Marilia, et al.
Publicado: (2020)

Allopurinol Is an Independent Determinant of Improved Arterial Stiffness in Chronic Kidney Disease: A Cross-Sectional Study
por: Ng, Khai P., et al.
Publicado: (2014)

Prevention Effect of Allopurinol on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Meta-Analysis of Prospective Randomized Controlled Trials
por: Cao, Wei-Li, et al.
Publicado: (2014)

Allopurinol induced erythroderma
por: Sharma, Geeta, et al.
Publicado: (2013)

Allopurinol: Sorrow to the marrow
por: Raaju, UR, et al.
Publicado: (2020)

Allopurinol hypersensitivity syndrome
por: Yaseen, Wid, et al.
Publicado: (2023)

Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol
por: Dalbeth, Nicola, et al.
Publicado: (2018)

Unsupervised Exercise and Mobility Loss in Peripheral Artery Disease: A Randomized Controlled Trial
por: McDermott, Mary M, et al.
Publicado: (2015)

Switching from allopurinol to febuxostat: efficacy and safety in the treatment of hyperuricemia in renal transplant recipients
por: Li, Yanchun, et al.
Publicado: (2019)

Allopurinol for prevention of progression of kidney disease with hyperuricemia
por: Pai, B. H. Santhosh, et al.
Publicado: (2013)

Predictors of walking capacity in peripheral arterial disease patients
por: Farah, Breno Quintella, et al.
Publicado: (2013)

Effects of allopurinol and vitamin E on renal function in patients with cardiac coronary artery bypass grafts
por: Nouri-Majalan, Nader, et al.
Publicado: (2009)

Allopurinol-induced DRESS syndrome
por: Yaylacı, Selcuk, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p0mc4e95kin4t3iim6sb6i5mll